RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
An analysis of the slowdown in growth of spending for psychiatric drugs, 1986–2008
Kassed, C., Levit, K. R., Vandivort, R., & Mark, T. (2012). An analysis of the slowdown in growth of spending for psychiatric drugs, 1986–2008. Psychiatric Services, 63(1), 13-18. https://doi.org/10.1176/appi.ps.201100564
From 1993 to 2003, spending on medications was a major factor in unprecedented growth in mental health spending. An analysis of current trends shows that past high growth in spending on psychiatric drugs has slowed substantially—from an average annual growth rate of nearly 19% in 1997–2001 to 6% in 2001–2008. The increased entry of generic medications, which constituted 70% of all psychiatric prescriptions by 2008, was a key contributor to the slowdown in spending.
